FI964669A - Triatsolyylitryptamiinin palladiumkatalysoitu renkaanmuodostus - Google Patents

Triatsolyylitryptamiinin palladiumkatalysoitu renkaanmuodostus Download PDF

Info

Publication number
FI964669A
FI964669A FI964669A FI964669A FI964669A FI 964669 A FI964669 A FI 964669A FI 964669 A FI964669 A FI 964669A FI 964669 A FI964669 A FI 964669A FI 964669 A FI964669 A FI 964669A
Authority
FI
Finland
Prior art keywords
palladium
catalyzed ring
triazolyltryptamine
ring formation
tryptamine
Prior art date
Application number
FI964669A
Other languages
English (en)
Swedish (sv)
Other versions
FI116899B (fi
FI964669A0 (fi
Inventor
Cheng Y Chen
Robert D Larsen
Thomas R Verhoeven
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI964669A publication Critical patent/FI964669A/fi
Publication of FI964669A0 publication Critical patent/FI964669A0/fi
Application granted granted Critical
Publication of FI116899B publication Critical patent/FI116899B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Inorganic Insulating Materials (AREA)
FI964669A 1994-05-24 1996-11-22 Triatsolyylitryptamiinin palladiumkatalysoitu renkaanmuodostus FI116899B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24828894 1994-05-24
US08/248,288 US5567824A (en) 1994-05-24 1994-05-24 Palladium catalyzed ring closure of triazolyltryptamine
US9505506 1995-05-19
PCT/US1995/005506 WO1995032197A1 (en) 1994-05-24 1995-05-19 Palladium catalyzed ring closure of triazolyl tryptamine

Publications (3)

Publication Number Publication Date
FI964669A true FI964669A (fi) 1996-11-22
FI964669A0 FI964669A0 (fi) 1996-11-22
FI116899B FI116899B (fi) 2006-03-31

Family

ID=22938473

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964669A FI116899B (fi) 1994-05-24 1996-11-22 Triatsolyylitryptamiinin palladiumkatalysoitu renkaanmuodostus

Country Status (24)

Country Link
US (1) US5567824A (fi)
EP (1) EP0763032B1 (fi)
JP (1) JP3947216B2 (fi)
KR (1) KR100385027B1 (fi)
CN (2) CN1077104C (fi)
AT (1) ATE252095T1 (fi)
AU (1) AU688505B2 (fi)
DE (1) DE69531939T2 (fi)
DK (1) DK0763032T3 (fi)
ES (1) ES2207648T3 (fi)
FI (1) FI116899B (fi)
HK (2) HK1009045A1 (fi)
HR (1) HRP950304B1 (fi)
HU (1) HU226460B1 (fi)
MX (1) MX9605838A (fi)
NZ (1) NZ285539A (fi)
PT (1) PT763032E (fi)
RO (1) RO118586B1 (fi)
RU (1) RU2138496C1 (fi)
SK (1) SK284495B6 (fi)
TW (1) TW300221B (fi)
UA (1) UA52586C2 (fi)
WO (1) WO1995032197A1 (fi)
YU (1) YU49345B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA965837B (en) * 1995-07-11 1997-01-31 Merck & Co Inc A triazolylmethyl-indole ethylamine bisulfate salt
DE69616335T2 (de) * 1995-07-11 2002-07-11 Merck & Co Inc Ein triazolylmethyl-indol-ethylamin-bisulfat-salz
US5808064A (en) * 1996-08-13 1998-09-15 Merck & Co., Inc. Palladium catalyzed indolization
US5877329A (en) * 1996-08-13 1999-03-02 Merck & Co., Inc. Palladium catalyzed indolization
AU4053497A (en) * 1996-08-13 1998-03-06 Merck & Co., Inc. Palladium catalyzed indolization
US5811551A (en) * 1996-08-13 1998-09-22 Merck & Co., Inc. Palladium catalyzed indolization
EE04592B1 (et) * 1999-06-28 2006-02-15 Janssen Pharmaceutica N.V. Respiratoorse süntsütiaalviiruse replikatsiooni inhibiitorid, nende valmistamismeetod, kasutamine ja vaheühendid, farmatseutiline kompositsioon ja selle valmistamismeetod ning produkt
ES2204303B2 (es) * 2002-08-07 2004-12-16 Laboratorios Vita, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
CA2552663A1 (en) * 2004-01-09 2005-07-28 Ratiopharm Gmbh Crystalline forms of rizatriptan benzoate
DK1751104T3 (da) 2004-01-28 2010-06-07 Ratiopharm Gmbh Syntesemetoder og mellemprodukter til fremstilling af rizatriptan
PA8626701A1 (es) * 2004-03-26 2006-05-16 Wyeth Corp Procedimientos para la preparacion de compuestos aminoarilos yodados
WO2006082598A2 (en) * 2005-02-01 2006-08-10 Natco Pharma Limited Novel crystalline forms of rizatriptan benzoate
WO2006137083A1 (en) * 2005-06-20 2006-12-28 Natco Pharma Limited Improved process for the preparation of rizatriptan benzoate
EP1951713A1 (en) * 2005-11-14 2008-08-06 Matrix Laboratories Ltd Process for the large scale production of rizatriptan benzoate
EP1981860B1 (en) * 2006-01-19 2011-05-25 Matrix Laboratories Ltd Conversion of aromatic diazonium salt to aryl hydrazine
EP2160390A1 (en) * 2007-06-04 2010-03-10 Generics Ýuk¨Limited Novel process
EP3407869A1 (en) 2016-01-27 2018-12-05 Instar Technologies A.S. Oromucosal nanofiber carriers for therapeutic treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
GB9215526D0 (en) * 1992-07-22 1992-09-02 Merck Sharp & Dohme Chemical process

Also Published As

Publication number Publication date
KR100385027B1 (ko) 2003-08-14
NZ285539A (en) 1998-06-26
AU688505B2 (en) 1998-03-12
DE69531939D1 (de) 2003-11-20
RU2138496C1 (ru) 1999-09-27
UA52586C2 (uk) 2003-01-15
FI116899B (fi) 2006-03-31
EP0763032B1 (en) 2003-10-15
AU2467195A (en) 1995-12-18
YU49345B (sh) 2005-07-19
HK1041262A1 (en) 2002-07-05
DK0763032T3 (da) 2004-02-09
HK1009045A1 (en) 1999-05-21
HU9603236D0 (en) 1997-01-28
CN1157390C (zh) 2004-07-14
ATE252095T1 (de) 2003-11-15
HK1041262B (zh) 2005-04-15
HRP950304A2 (en) 1997-08-31
JPH10500680A (ja) 1998-01-20
SK149896A3 (en) 1997-09-10
WO1995032197A1 (en) 1995-11-30
SK284495B6 (sk) 2005-05-05
CN1152920A (zh) 1997-06-25
ES2207648T3 (es) 2004-06-01
RO118586B1 (ro) 2003-07-30
US5567824A (en) 1996-10-22
EP0763032A1 (en) 1997-03-19
FI964669A0 (fi) 1996-11-22
PT763032E (pt) 2004-02-27
JP3947216B2 (ja) 2007-07-18
HRP950304B1 (en) 2004-12-31
MX9605838A (es) 1997-12-31
CN1077104C (zh) 2002-01-02
TW300221B (fi) 1997-03-11
YU33495A (sh) 1998-07-10
DE69531939T2 (de) 2004-07-29
HUT76469A (en) 1997-09-29
CN1322725A (zh) 2001-11-21
HU226460B1 (en) 2008-12-29
KR970703336A (ko) 1997-07-03

Similar Documents

Publication Publication Date Title
FI964669A (fi) Triatsolyylitryptamiinin palladiumkatalysoitu renkaanmuodostus
US5166170A (en) 2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders
FI820295L (fi) Nya kefemkompositioner och foerfarande foer deras framstaellning
PT74626A (en) Process for preparing 9-<2-(3-indolyl)ethyl>-1-oxa-4,9-diazas- piro<5,5>undecan-3-ones
NO963117L (no) Indol-derivater som 5-HT1-agonister
US5214059A (en) 2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders
JP2000204026A (ja) ケラチン繊維の染色におけるカチオン性のジベンゼン性ニトロ化合物の用途、染色用組成物及び染色方法
YU217181A (en) Process for preparing 2-(1,4-benzodioxane-2-ylalkyl)-imidazoles
KR840004746A (ko) 2-옥소-1-아제티딘술폰산 유도체의 제조방법
JPS5359663A (en) 2-halogeno methyl indole derivatives and process for praparation of the same
DK432086D0 (da) Fremgangsmaade til fremstilling af beta-lactamforbindelser eller saltederaf
DK501480A (da) Fremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazoliner-(2).
CA2190851A1 (en) Palladium catalyzed ring closure of triazolyl tryptamine
ES8307766A1 (es) Procedimiento para la preparacion de derivados de azolil-penteno.
HUP0001596A2 (hu) Eljárás 5-(amino-metil)-2-klór-piridin-származékok előállítására
ES8407042A1 (es) Procedimiento para la obtencion de un nuevo derivado del sulpiride.
JPH0356452A (ja) 安息香酸誘導体の製造方法
AU519287B2 (en) Imidazo(1,2-alpha) imidazole derivatives
JP2997724B2 (ja) フタリド化合物の製造方法
CA1055017A (en) Process for amidation and esterification
DK531080A (da) Fremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazoliner eller syreadditionssalte deraf
HUP9701476A2 (hu) Eljárás dexfenfluramin-hidroklorid előállítására és intermedierjeik
HU9302786D0 (en) New thiophene-2-carboxylic acid derivatives and process for preparing them
KR970042548A (ko) 이미다조 피리딘 유도체,이의 제조방법 및 이를 함유한 약제학적 조성물
GB2011897A (en) Process for Preparing Anthranylaldehyde Derivatives

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116899

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

Free format text: MERCK SHARP & DOHME CORP.

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

MA Patent expired